Original Article

You have full text access to this OnlineOpen article

Genetic susceptibility of lung cancer associated with common variants in the 3′ untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export

  1. Haijian Wang PhD1,2,†,
  2. Guangfu Jin PhD3,†,
  3. Haifeng Wang PhD4,
  4. Gaifen Liu PhD5,
  5. Ji Qian MS1,
  6. Li Jin PhD1,
  7. Qingyi Wei MD, PhD6,
  8. Hongbing Shen MD, PhD3,
  9. Wei Huang MD, PhD4,
  10. Daru Lu PhD1,‡,*

Article first published online: 23 DEC 2008

DOI: 10.1002/cncr.24042

Issue

Cancer

Cancer

Volume 115, Issue 3, pages 595–607, 1 February 2009

Additional Information

How to Cite

Wang, H., Jin, G., Wang, H., Liu, G., Qian, J., Jin, L., Wei, Q., Shen, H., Huang, W. and Lu, D. (2009), Genetic susceptibility of lung cancer associated with common variants in the 3′ untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export. Cancer, 115: 595–607. doi: 10.1002/cncr.24042

Author Information

  1. 1

    State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

  2. 2

    The Simons Center for Systems Biology, School of Natural Sciences, Institute for Advanced Study, Princeton, New Jersey

  3. 3

    Department of Epidemiology and Biostatistics, Cancer Research Center, Nanjing Medical University, Nanjing, China

  4. 4

    Department of Genetics, Chinese National Human Genome Center at Shanghai, Shanghai, China

  5. 5

    Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands

  6. 6

    Department of Epidemiology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    The first 2 authors contributed equally to this article.

  2. ‡

    Fax: (011) 86 21 65642799

*State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China

Publication History

  1. Issue published online: 20 JAN 2009
  2. Article first published online: 23 DEC 2008
  3. Manuscript Accepted: 4 AUG 2008
  4. Manuscript Revised: 14 JUL 2008
  5. Manuscript Received: 24 MAR 2008

Funded by

  • National Basic Research Program of China. Grant Numbers: 2002CB512902, 2002BA711A10, 2004CB518605
  • Shanghai Science and Technology Developing Program. Grant Number: 06DZ19502
  • Program for New Century Excellent Talents in University. Grant Number: NCET-07-0204
  • Shanghai Rising-Star Program. Grant Number: 07QA14006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (184K)

References

  • 1
    Correa E,Joshi PA,Castonguay A,Schuller HM. The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res. 1990; 50: 3435-3438.
  • 2
    Schuller HM,Witschi HP,Nylen E,Joshi PA,Correa E,Becker KL. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res. 1990; 50: 1960-1965.
  • 3
    Jin Z,Gao F,Flagg T,Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem. 2004; 279: 40209-40219.
  • 4
    Su T,Bao Z,Zhang QY,Smith TJ,Hong JY,Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000; 60: 5074-5079.
  • 5
    Schuller HM,Tithof PK,Williams M,Plummer H,3rd. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 1999; 59: 4510-4515.
  • 6
    Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer. 2002; 2: 455-463.
  • 7
    Kim PM,Wells PG. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Cancer Res. 1996; 56: 1526-1532.
  • 8
    Leslie EM,Ito K,Upadhyaya P,Hecht SS,Deeley RG,Cole SP. Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem. 2001; 276: 27846-27854.
  • 9
    Leslie EM,Deeley RG,Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005; 204: 216-237.
  • 10
    Zhang X,Su T,Zhang QY, et al. Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J Pharmacol Exp Ther. 2002; 302: 416-423.
  • 11
    Wang H,Tan W,Hao B, et al. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 2003; 63: 8057-8061.
  • 12
    Wang H,Hao B,Chen X, et al. Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: a case-control study in a Chinese population. Cancer Lett. 2006; 240: 297-305.
  • 13
    Gallagher CJ,Muscat JE,Hicks AN, et al. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16: 823-828.
  • 14
    Araki J,Kobayashi Y,Iwasa M, et al. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. Eur J Cancer. 2005; 41: 2360-2365.
  • 15
    Scheffer GL,Pijnenborg AC,Smit EF, et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol. 2002; 55: 332-339.
  • 16
    Berger W,Setinek U,Hollaus P, et al. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol. 2005; 131: 355-363.
  • 17
    Campling BG,Young LC,Baer KA, et al. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin Cancer Res. 1997; 3: 115-122.
  • 18
    Penny JI,Campbell FC. Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium. Biochim Biophys Acta. 1994; 1226: 232-236.
  • 19
    Phang JM,Poore CM,Lopaczynska J,Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res. 1993; 53: 5977-5981.
  • 20
    van Herwaarden AE,Jonker JW,Wagenaar E, et al. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 2003; 63: 6447-6452.
  • 21
    van der Deen M,de Vries EG,Timens W,Scheper RJ,Timmer-Bosscha H,Postma DS. ATP-binding cassette (ABC) transporters in normal and pathological lung [serial online]. Respir Res. 2005; 6: 59.
  • 22
    Hoffmeyer S,Burk O,von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA. 2000; 97: 3473-3478.
  • 23
    Chinn LW,Kroetz DL. ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther. 2007; 81: 265-269.
  • 24
    Conseil G,Deeley RG,Cole SP. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet Genomics. 2005; 15: 523-533.
  • 25
    Wang H,Hao B,Zhou K, et al. Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association studies. Ann Hum Genet. 2004; 68(pt 6): 563-573.
    Direct Link:
  • 26
    Wang H,Ding K,Zhang Y,Jin L,Kullo IJ,He F. Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions. Pharmacogenet Genomics. 2007; 17: 667-678.
  • 27
    Kohno K,Sato S,Uchiumi T,Takano H,Kato S,Kuwano M. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem. 1990; 265: 19690-19696.
  • 28
    Hu Z,Wang H,Shao M, et al. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis. Hum Mutat. 2007; 28: 431-440.
    Direct Link:
  • 29
    Stephens M,Smith NJ,Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001; 68: 978-989.
  • 30
    Ding K,Zhou K,He F,Shen Y. LDA--a Java-based linkage disequilibrium analyzer. Bioinformatics. 2003; 19: 2147-2148.
  • 31
    Sham PC,Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995; 59(pt 1): 97-105.
    Direct Link:
  • 32
    Wallenstein S,Hodge SE,Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol. 1998; 15: 173-181.
    Direct Link:
  • 33
    Saunders MA,Liang H,Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA. 2007; 104: 3300-3305.
  • 34
    Sethupathy P,Borel C,Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007; 81: 405-413.
  • 35
    Martin MM,Buckenberger JA,Jiang J, et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem. 2007; 282: 24262-24269.
  • 36
    Yu Z,Li Z,Jolicoeur N, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007; 35: 4535-4541.
  • 37
    Risch HA,Howe GR,Jain M,Burch JD,Holowaty EJ,Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993; 138: 281-293.
  • 38
    Zang EA,Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996; 88: 183-192.
  • 39
    Henschke CI,Yip R,Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 2006; 296: 180-184.
  • 40
    Bain C,Feskanich D,Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst. 2004; 96: 826-834.
  • 41
    Taioli E,Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 1994; 86: 869-870.
  • 42
    Gao YT,Blot WJ,Zheng W, et al. Lung cancer among Chinese women. Int J Cancer. 1987; 40: 604-609.
    Direct Link:
  • 43
    Fasco MJ,Hurteau GJ,Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002; 188: 125-140.
  • 44
    Stabile LP,Davis AL,Gubish CT, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002; 62: 2141-2150.
  • 45
    Patel JD. Lung cancer in women. J Clin Oncol. 2005; 23: 3212-3218.
  • 46
    Spivack SD,Hurteau GJ,Fasco MJ,Kaminsky LS. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res. 2003; 9(16 pt 1): 6002-6011.
  • 47
    Imai Y,Ishikawa E,Asada S,Sugimoto Y. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 2005; 65: 596-604.
  • 48
    Mutoh K,Tsukahara S,Mitsuhashi J,Katayama K,Sugimoto Y. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci. 2006; 97: 1198-1204.
    Direct Link:
  • 49
    Merino G,van Herwaarden AE,Wagenaar E,Jonker JW,Schinkel AH. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol Pharmacol. 2005; 67: 1765-1771.
  • 50
    Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998; 11: 559-603.
  • 51
    Wynder EL,Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res. 1994; 54: 5284-5295.
  • 52
    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91: 1194-1210.
  • 53
    Deutsch-Wenzel RP,Brune H,Grimmer G,Dettbarn G,Misfeld J. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J Natl Cancer Inst. 1983; 71: 539-544.
  • 54
    Song N,Tan W,Xing D,Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis. 2001; 22: 11-16.
  • 55
    Nakachi K,Imai K,Hayashi S,Watanabe J,Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 1991; 51: 5177-5180.
  • 56
    Le Marchand L,Sivaraman L,Pierce L, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 1998; 58: 4858-4863.
  • 57
    Minna JD,Roth JA,Gazdar AF. Focus on lung cancer. Cancer Cell. 2002; 149-152.
  • 58
    Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002; 21: 6870-6876.
  • 59
    Radzikowska E,Roszkowski K,Glaz P. Lung cancer in patients under 50 years old. Lung Cancer. 2001; 33: 203-211.
  • 60
    Sinues B,Fanlo A,Bernal ML, et al. MDR-1 C3435T genetic polymorphism and tobacco-related lung cancer. Oncology. 2003; 64: 183-185.
  • 61
    Gervasini G,Carrillo JA,Garcia M,San Jose C,Cabanillas A,Benitez J. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer. 2006; 107: 2850-2857.
    Direct Link:
View Full Article (HTML) Get PDF (184K)